I n clinical thermography the amount of heat energy received by the detector is interpreted in terms of a distribution of skin temperature but it also depends on the emissivity of the surface. I t has been concluded previously that the emissivity in the range 2-5 pm for skin at normal incidence is about 0.98, and that variations are not likely to represent a difference in apparent temperature of more than f 0 . 5 ' ~. However, theoretical considerations are presented for the variat'ion of emissivity with the angle a t which the surface is viewed. These indicate a significant fall in emissivity as the angle to the normal is increased beyond go", corresponding to a reduction of 4"c or more in apparent surface temperature. Thus it would be possible for a ' hot spot ' associated with significant pathology to remain undetected on a surface viewed obliquely. Examples of this obliquity effect in clinical and experimental thermographs are demonstrated.
A case of parenchymal and intraparotid lymph node tuberculosis is reported in a young Asian male. The diagnosis was suggested pre-operatively by the contrast enhanced CT (CECT) appearance. There were no systemic symptoms of tuberculosis and this is a characteristic feature of the 100 cases reported in the literature. The presence of thick walled rim enhancing lesions with a central lucency on CECT should suggest the diagnosis. Filling defects with or without thin walls are non-specific findings and are seen in tumours and other inflammatory processes. In an appropriate clinical setting, thick walled round rim enhancing lesions with a central lucency are characteristic of tuberculosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.